India Pharma Outlook | Friday, 05 September 2025
Granules India Limited, in collaboration with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, has officially opened the Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD).
This CSR initiative by Granules is designed to empower students and researchers by providing access to state-of-the-art facilities and resources, thereby promoting innovation in Healthcare and offering environmentally friendly solutions for pharmaceutical manufacturing education.
It is an important move for the company's future vision of integrating sustainability into its operations. Furthermore, by entrenching technological breakthrough into green practices, Granules India's goals are not only amplifying operational efficiency but also contributing to society and the environment in a positive manner. The company strongly believes that long-term success comes with strong fundamentals such as ethical responsibility and environmental stewardship.
Also Read: KalVista's Genetic Disease Treatment Triumphs in Late-Stage Study
Speaking at the inauguration, Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited said, “At Granules, we believe that innovation and sustainability go hand in hand. Guided by our purpose of Healing Lives Responsibly through Pioneering Green Science, this initiative reflects our commitment to shaping a healthier, more sustainable future, not only for our stakeholders, but also for the communities and ecosystems that sustain us.”
Prof. Dulal Panda, Director, NIPER S.A.S Nagar said, "This collaboration brings academia and industry together to solve real-world challenges. By focusing on green and sustainable practices, we can deliver solutions that benefit both the environment and patients worldwide."